Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have been assigned a consensus rating of “Hold” from the fifteen analysts that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and eight have given a buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $30.69.
Several brokerages recently issued reports on ACHC. Guggenheim increased their price objective on Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. Leerink Partners boosted their target price on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research note on Wednesday, September 23rd. KeyCorp upped their target price on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th. Finally, Raymond James Financial lowered Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price target for the company. in a report on Monday, September 28th.
Read Our Latest Analysis on Acadia Healthcare
Key Stories Impacting Acadia Healthcare
Here are the key news stories impacting Acadia Healthcare this week:
- Positive Sentiment: Acadia reported third-quarter adjusted earnings of $0.60 per share, above analysts’ $0.46 estimate, and revenue of $895.3 million, also ahead of expectations. Revenue increased 5.1% year over year. Acadia Healthcare Surpasses Q3 Earnings and Revenue Estimates
- Positive Sentiment: The company raised its full-year 2026 financial guidance; reports described the revised outlook as slightly above expectations. That signals improved confidence in the year’s performance. Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance Acadia Healthcare Exceeds Q3 Expectations
- Positive Sentiment: Same-facility revenue grew 5.2%, supported by a 1.1% increase in patient days and a 4.0% increase in revenue per patient day. Acadia Healthcare Third-Quarter Results
- Negative Sentiment: Despite beating estimates, quarterly earnings per share declined from $0.72 in the year-ago quarter to $0.60, a year-over-year comparison that may temper the positive reaction.
Acadia Healthcare Stock Performance
ACHC opened at $32.25 on Monday. The firm has a market cap of $3.00 billion, a PE ratio of -2.59, a P/E/G ratio of 9.54 and a beta of 0.64. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The business has a fifty day simple moving average of $29.18 and a 200-day simple moving average of $25.91. Acadia Healthcare has a fifty-two week low of $11.43 and a fifty-two week high of $35.83.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its earnings results on Wednesday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.14. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%. The business had revenue of $895.31 million for the quarter, compared to analysts’ expectations of $877.76 million. During the same period in the previous year, the firm posted $0.72 EPS. The company’s quarterly revenue was up 5.1% on a year-over-year basis. As a group, equities analysts predict that Acadia Healthcare will post 1.55 EPS for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the stock. Allworth Financial LP bought a new stake in shares of Acadia Healthcare in the second quarter valued at approximately $45,000. Global Retirement Partners LLC bought a new position in Acadia Healthcare during the second quarter worth $68,000. Integrated Wealth Concepts LLC bought a new position in Acadia Healthcare during the second quarter worth $79,000. Quantbot Technologies LP acquired a new position in Acadia Healthcare during the 2nd quarter valued at $88,000. Finally, Pinnacle Wealth Planning Services Inc. raised its stake in Acadia Healthcare by 20.7% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 3,209 shares of the company’s stock valued at $88,000 after purchasing an additional 550 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.
Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.
Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
